rs143240767
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_206933.4(USH2A):c.8342C>T(p.Thr2781Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,614,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T2781A) has been classified as Uncertain significance.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.8342C>T | p.Thr2781Ile | missense_variant | 42/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.8342C>T | p.Thr2781Ile | missense_variant | 42/72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.8342C>T | p.Thr2781Ile | missense_variant | 42/73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 250774Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135582
GnomAD4 exome AF: 0.000218 AC: 319AN: 1461828Hom.: 0 Cov.: 32 AF XY: 0.000205 AC XY: 149AN XY: 727218
GnomAD4 genome AF: 0.000230 AC: 35AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74468
ClinVar
Submissions by phenotype
Usher syndrome type 2A Uncertain:1Benign:3
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in patients with USH2A-related disorders together with variants of uncertain significance (phase unknown) in the USH2A gene in published literature (PMID: 36819107, 23767834); This variant is associated with the following publications: (PMID: 36819107, 30245029, 23767834) - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 22, 2021 | Variant summary: USH2A c.8342C>T (p.Thr2781Ile) results in a non-conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 301738 control chromosomes, predominantly at a frequency of 0.012 within Japanese subpopulation (gnomAD, other databases, publication data). This frequency is equal to the estimated maximal expected allele frequency of a pathogenic variant in USH2A causing Usher Syndrome (0.012 vs 0.011), suggesting this may be a benign polymorphism found primarily in Japanese subpopulation. c.8342C>T has been reported in the literature in deaf patients (Yang_2013, He_2018). These reports do not provide unequivocal conclusions about association of the variant with Usher Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Seven ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance (n=2), likely benign (n=4) and benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 17, 2014 | Thr2781Ile in exon 42 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 2.8% (5/178) of Japanese chromosome s by the 1000 Genomes project (rs143240767). While it has been identified in on e individual with hearing loss (Yang 2013), based on the population frequency, t his variant is likely benign. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 20, 2017 | - - |
Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at